ropivacaine

1
Reactions 1357 - 25 Jun 2011 S Ropivacaine Reversible posterior leukoencephalopathy syndrome and hypotension: case report A 59-year-old woman developed reversible posterior leucoencephalopathy syndrome (RPLS) and hypotension during treatment with ropivacaine for abdominal pain control following a cholecystectomy. The woman received ropivacaine 8-12 mg/hour via an epidural catheter everyday postoperatively. She had a history of chronic hypertension and also received candesartan cilexetil to maintain her BP at around 150/80. Four days after the operation, she experienced a mild headache on rising in the morning, and as her BP was 89/46, she did not receive candesartan cilexetil. While eating breakfast, she experienced blurred vision in the lower half of the visual field. MRI revealed numerous high- intensity areas in bilateral occipital and right parietal and frontal lobes. Intracranial magnetic resonance angiography revealed significant bilateral, diffuse peripheral arterial constriction in the middle, anterior and posterior cerebral arteries. The epidural catheter was removed and the woman received low molecular weight dextran. Her BP was 114/92, and subsequently returned to 143/82. Her antihypertensive drug was restarted 5 days after symptom onset. Three days after treatment, she experienced no further episodes of visual disturbance or headache. Complete resolution of high-intensity areas was noted on repeat MRI 1 month after treatment and the peripheral arterial constriction had resolved on repeat magnetic resonance angiography. RPLS was diagnosed based on the imaging evidence and her complete recovery. Author comment: "RPLS, in our case, was caused by the toxic effects of ropivacaine, and hypotension may have been induced by the toxic effects of the drugs. The patient’s BP easily returned to normal range as soon as administration of ropivacaine was stopped." Yamada SM, et al. A case of reversible posterior leukoencephalopathy syndrome with acute hypotension. Neurological Sciences 32: 165-8, No. 1, Feb 2011 - Japan 803056006 1 Reactions 25 Jun 2011 No. 1357 0114-9954/10/1357-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved

Upload: phamtram

Post on 18-Mar-2017

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ropivacaine

Reactions 1357 - 25 Jun 2011

SRopivacaine

Reversible posterior leukoencephalopathysyndrome and hypotension: case report

A 59-year-old woman developed reversible posteriorleucoencephalopathy syndrome (RPLS) and hypotensionduring treatment with ropivacaine for abdominal paincontrol following a cholecystectomy.

The woman received ropivacaine 8-12 mg/hour via anepidural catheter everyday postoperatively. She had ahistory of chronic hypertension and also receivedcandesartan cilexetil to maintain her BP at around 150/80.Four days after the operation, she experienced a mildheadache on rising in the morning, and as her BP was89/46, she did not receive candesartan cilexetil. Whileeating breakfast, she experienced blurred vision in thelower half of the visual field. MRI revealed numerous high-intensity areas in bilateral occipital and right parietal andfrontal lobes. Intracranial magnetic resonance angiographyrevealed significant bilateral, diffuse peripheral arterialconstriction in the middle, anterior and posterior cerebralarteries.

The epidural catheter was removed and the womanreceived low molecular weight dextran. Her BP was114/92, and subsequently returned to 143/82. Herantihypertensive drug was restarted 5 days after symptomonset. Three days after treatment, she experienced nofurther episodes of visual disturbance or headache.Complete resolution of high-intensity areas was noted onrepeat MRI 1 month after treatment and the peripheralarterial constriction had resolved on repeat magneticresonance angiography. RPLS was diagnosed based on theimaging evidence and her complete recovery.

Author comment: "RPLS, in our case, was caused by thetoxic effects of ropivacaine, and hypotension may have beeninduced by the toxic effects of the drugs. The patient’s BPeasily returned to normal range as soon as administration ofropivacaine was stopped."Yamada SM, et al. A case of reversible posterior leukoencephalopathy syndromewith acute hypotension. Neurological Sciences 32: 165-8, No. 1, Feb 2011 -Japan 803056006

1

Reactions 25 Jun 2011 No. 13570114-9954/10/1357-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved